BioWorld

April 21, 2003

GeneSoft Adds Government Grant to Factive Approval

As a small privately held company with 22 employees, GeneSoft Pharmaceuticals Inc. appears to be on a roll, finding its niche in three different areas of drug development. (BioWorld Today) Read More

Protein Pathways Lands Merck In First Technology Partnership

U.S., French Researchers Report In Nature, Science Mutant Gene

Protein Mechanics Pursues In Silico Drug Development

Appointments And Advancements

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...